Yen‐Ling Peng
Yen‐Ling Peng publishes mostly in Hematology, Genetics and Molecular Biology, on topics such as Acute Myeloid Leukemia Research, Myeloproliferative Neoplasms: Diagnosis and Treatment and Chronic Myeloid Leukemia Treatments.
- World rank
- #1,082,490 of 7,710,434 ranked researchers
- Rank in Taiwan
- #5,300 of 57,035
- Works
- 39
- Citations
- 595
- Citations per work
- 15.3
What does Yen‐Ling Peng research?
Yen‐Ling Peng's work is mostly in Medicine (60%), Biochemistry, Genetics and Molecular Biology (18%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Health Sciences2359.6%
- Medicine2359.6%
- Everything else922.9%
- Life Sciences717.5%
- 1Hematology31% of their works
- 2Genetics18% of their works
- 3Molecular Biology10% of their works
- 4Cancer Research7% of their works
- 5Pulmonary and Respiratory Medicine6% of their works
- 6Surgery5% of their works
Research topics
- Acute Myeloid Leukemia Research
- Myeloproliferative Neoplasms: Diagnosis and Treatment
- Chronic Myeloid Leukemia Treatments
- Cancer Genomics and Diagnostics
- Histone Deacetylase Inhibitors Research
- Helicobacter pylori-related gastroenterology studies
- Protein Degradation and Inhibitors
- Antiplatelet Therapy and Cardiovascular Diseases
Which keywords describe Yen‐Ling Peng's research?
The keywords of their largest research topics: Acute Myeloid Leukemia, AML, JAK2 Mutation, Myelofibrosis, BCR-ABL, Imatinib, Cancer Genomics and Mutational Signatures.
- PROTACs
- BET Bromodomains
- Histone Deacetylases
- HDAC Inhibitors
- Mutational Signatures
- Imatinib
- Myelofibrosis
- Acute Myeloid Leukemia
- AML
- JAK2 Mutation
- BCR-ABL
- Cancer Genomics
- Gastric Cancer
- Helicobacter pylori
- Aspirin
- Clopidogrel
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most.
All 16 words, with their numbers
- AML251 topic
- Acute Myeloid Leukemia251 topic
- JAK2 Mutation181 topic
- Myelofibrosis181 topic
- BCR-ABL61 topic
- Imatinib61 topic
- Cancer Genomics51 topic
- Mutational Signatures51 topic
- Gastric Cancer41 topic
- HDAC Inhibitors41 topic
- Helicobacter pylori41 topic
- Histone Deacetylases41 topic
- Aspirin31 topic
- BET Bromodomains31 topic
- Clopidogrel31 topic
- PROTACs31 topic
Where does Yen‐Ling Peng work?
Yen‐Ling Peng's main affiliation in the publication record is National Taiwan University Hospital, Taiwan.
How many publications and citations does Yen‐Ling Peng have?
OpenAlex counts 39 works and 595 citations for Yen‐Ling Peng, an h-index of 12, ranking #1,082,490 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Yen‐Ling Peng. Posts are plain text and can be reported.